-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Spta3A1/s1D0RJwJQPe3PhVEH84MunFR+GQW2eijDbtYHiPMHbI7Bw4vztkXc5iI HXXg3CW5sPvGTl+OAPXJ+w== 0001209191-04-013478.txt : 20040301 0001209191-04-013478.hdr.sgml : 20040301 20040301185722 ACCESSION NUMBER: 0001209191-04-013478 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20040301 FILED AS OF DATE: 20040301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RENTON HOLLINGS CENTRAL INDEX KEY: 0001187333 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-28298 FILM NUMBER: 04640703 BUSINESS ADDRESS: STREET 1: ONYX PHARMACEUTICALS STREET 2: 3031 RESEARCH DRIVE CITY: RICHMOND STATE: CA ZIP: 94806 BUSINESS PHONE: 5102628769 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ONYX PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001012140 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943154463 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3031 RESEARCH DR STREET 2: BLDG A CITY: RICHMOND STATE: CA ZIP: 94806 BUSINESS PHONE: 5102229700 MAIL ADDRESS: STREET 1: 3031 RESEARCH DRIVE CITY: RICHMOND STATE: CA ZIP: 94806 4 1 doc4.xml FORM 4 SUBMISSION X0201 4 2004-03-01 0 0001012140 ONYX PHARMACEUTICALS INC ONXX 0001187333 RENTON HOLLINGS C/O ONYX PHARMACEUTICALS, INC. 3031 RESEARCH DR., BLDG. A RICHMOND CA 94806 1 1 0 0 President and CEO Common Stock 2004-03-01 4 S 0 1000.0000 36.6400 D 101389.0000 I Family Trust Common Stock 2004-03-01 4 S 0 300.0000 36.4800 D 101089.0000 I Family Trust Common Stock 2004-03-01 4 S 0 100.0000 36.4820 D 100989.0000 I Family Trust Common Stock 2004-03-01 4 S 0 600.0000 36.4700 D 100389.0000 I Family Trust Common Stock 2004-03-01 4 S 0 500.0000 36.4900 D 99889.0000 I Family Trust Reporting person is deemed to beneficially own an additional (i) 1,200 shares held by his spouse and (ii) 11,546 shares held directly by the reporting person (of which 4,985 were purchased on 6/30/03 and 411 were purchased on 12/31/03 pursuant to the issuer's employee stock purchase plan). /s/ Marilyn E. Wortzman, Attorney-in-Fact 2004-03-01 -----END PRIVACY-ENHANCED MESSAGE-----